title: Culture, Expansion, and Differentiation of Murine Megakaryocytes from Fetal Liver, Bone Marrow, and Spleen.
abstract: Megakaryocytes (MKs) are the source of circulating platelets and are readily recognized by their large size and distinctive morphology. Their poor representation in hematopoietic tissues often requires considerable ex vivo expansion to generate cells for biochemical and cell biological studies. These experimental protocols describe the assessment of megakaryocytic potential within hematopoietic precursor cells in the bone marrow by colony-forming assays and expansion and enrichment of MKs from cultured fetal liver or spleen or bone marrow cells. Although these MKs are not synchronized in their maturation, they can be enriched over an albumin step gradient, and one-third to one-half of recovered cells will typically elaborate proplatelets, the immediate precursors of blood platelets. Both protocols require recombinant thrombopoietin (TPO) as a growth factor. Support protocols describe methods for preparing fetal liver cells, identifying mature rodent MKs by staining for acetylcholinesterase activity, and staining (May-Grünwald-Giemsa) mixed populations on cytocentrifuged blood cell preparations.
authors.affiliation: Universitätsklinikum Würzburg, Chair of Experimental Biomedicine: Experimental Hemostaseology, Würzburg, Germany.
authors.forename: Harald
authors.initials: H
authors.lastname: Schulze
mesh_terms: D000110:Acetylcholinesterase / Q000378:metabolism; D000818:Animals; D001854:Bone Marrow Cells / Q000166:cytology*; D018929:Cell Culture Techniques; D002454:Cell Differentiation / Q000187:drug effects; D005333:Fetus / Q000166:cytology; D008099:Liver / Q000166:cytology* / Q000196:embryology; D008533:Megakaryocytes / Q000166:cytology* / Q000378:metabolism; D051379:Mice; D013154:Spleen / Q000166:cytology*; D013926:Thrombopoietin / Q000494:pharmacology
chemical_list: D013926:Thrombopoietin; D000110:Acetylcholinesterase
keywords: fetal liver culture; hematopoietic progenitors; megakaryocytes; platelets; thrombopoietin
references.citation: Chen, Z. , Hu, M. , and Shivdasani, R.A. 2007 Expression analysis of primary mouse megakaryocyte differentiation and its application in identifying stage-specific molecular markers and a novel transcriptional target of NF-E2. Blood 109:1451-1459. doi: 10.1182/blood-2006-08-038901.
references.citation: Choi, E.S. , Hokom, M.M. , Chen, J.L. , Skrine, J. , Faust, J. , Nichol, J. , and Hunt, P. 1996. The role of megakaryocyte growth and development factor in terminal stages of thrombopoiesis. Br. J. Haematol. 95:227-233. doi: 10.1046/j.1365-2141.1996.d01-1920.x.
references.citation: Cooper, S.H. and Broxmeyer, H.E. 2000. Measurement of interleukin 3 and other hematopoietic cytokines, such as GM-CSF, G-CSF, M-CSF, erythropoietin, steel factor, and Flt-3 ligand. Curr. Protoc. Immunol. 37:6.4.1-6.4.20.
references.citation: Donovan, J. and Brown, P. 2006. Euthanasia. Curr. Protoc. Immunol. 73:1.8.1-1.8.4.
references.citation: Eckly, A. , Strassel, C. , Cazenave, J.P. , Lanza, F. , Léon C. , and Gachet, C. 2012. Characterization of megakaryocyte development in the native bone marrow environment. Methods Mol. Biol. 788:175-192. doi: 10.1007/978-1-61779-307-3_13.
references.citation: Hofman, F.M. and Taylor, C.R. 2013. Immunohistochemistry. Curr. Protoc. Immunol. 103:21.4.1-21.4.26.
references.citation: Italiano, J.E. Jr. , Lecine, P. , Shivdasani, R.A. , and Hartwig, J.H. 1999. Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes. J. Cell. Biol. 147:1299-1312. doi: 10.1083/jcb.147.6.1299.
references.citation: Jackson, C.W. 1973. Cholinesterase as a possible marker for early cells of the megakaryocytic series. Blood 42:413-421.
references.citation: Kaushansky, K. 1995. Thrombopoietin: The primary regulator of platelet production. Blood 86:419-431.
references.citation: Kruisbeek, A. M. 2000. Isolation of mouse mononuclear cells. Curr. Protoc. Immunol. 39:3.1.1-3.1.5.
references.citation: Lecine, P. , Italiano, J.E. Jr. , Kim, S.W. , Villeval, J.L. , and Shivdasani, R.A. 2000. Hematopoietic-specific beta 1 tubulin participates in a pathway of platelet biogenesis dependent on the transcription factor NF-E2. Blood 96:1366-1373.
references.citation: Lecine, P. , Villeval, J.L. , Vyas, P. , Swencki, B. , Xu, Y. , and Shivdasani, R. 1998. Mice lacking transcription factor NF-E2 provide in vivo validation of the proplatelet model of thrombocytopoiesis and show a platelet production defect that is intrinsic to megakaryocytes. Blood 92:1608-1616.
references.citation: Schulze, H. 2012. Culture of murine megakaryocytes and platelets from fetal liver and bone marrow. Methods Mol. Biol. 788:193-203. doi: 10.1007/978-1-61779-307-3_14.
references.citation: Sitnicka, E. , Lin, N. , Priestley, G.V. , Fox, N. , Broudy, V.C. , Wolf, N.S. , and Kaushansky, K. 1996. The effect of thrombopoietin on the proliferation and differentiation of murine hematopoietic stem cells. Blood 87:4998-5005.
references.citation: Strassel, C. , Eckly, A. , Léon, C. , Moog, S. , Cazenave, J.P. , Gachet, C. , and Lanza, F. 2012. Hirudin and heparin enable efficient megakaryocyte differentiation of mouse bone marrow progenitors. Exp. Cell. Res. 318:25-32. doi: 10.1016/j.yexcr.2011.10.003.
references.citation: Strober, W. 2015. Trypan blue exclusion test of cell viability. Curr. Protoc. Immunol. 111:A3.B.1-A3.B.3. doi: 10.1002/0471142735.ima03bs111.
references.citation: Tiwari, S. , Italiano, J.E. Jr. , Barral, D.C. , Mules, E.H. , Novak, E.K. , Swank, R.T. , Seabra, M.C. , and Shivdasani, R.A. 2003. A role for Rab27b in NF-E2-dependent pathways of platelet formation. Blood 102:3970-3979. doi: 10.1182/blood-2003-03-0977.
references.citation: Zeigler, F.C. , de Sauvage, F. , Widmer, H.R. , Keller, G.A. , Donahue, C. , Schreiber, R.D. , Malloy, B. , Hass, P. , Eaton, D. , and Matthews, W. 1994. In vitro megakaryocytopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells. Blood 84:4045-4052.